B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects
Rheumatoid arthritis (RA) is a common, chronic, systemic autoimmune disease, and its clinical features are the proliferation of joint synovial tissue, the formation of pannus and the destruction of cartilage. The global incidence of RA is about 1%, and it is more common in women. The basic feature o...
Main Authors: | Fengping Wu, Jinfang Gao, Jie Kang, Xuexue Wang, Qing Niu, Jiaxi Liu, Liyun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.750753/full |
Similar Items
-
CD28− Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status
by: Charlotte Thompson, et al.
Published: (2020-05-01) -
The onset site of rheumatoid arthritis: the joints or the lung?
by: G. Cafaro, et al.
Published: (2016-12-01) -
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
by: Ulrike Steffen, et al.
Published: (2019-07-01) -
Serum Levels of IL-22 and ACPA in Patients with Rheumatoid Arthritis
by: Zainab A. Aldhaher, et al.
Published: (2018-06-01) -
Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
by: Xinyu Yang, et al.
Published: (2017-11-01)